Pharsight

Levitra generic

Levitra is a medication used to treat erectile dysfunction, owned by Bayer Hlthcare. Its active ingredient, vardenafil hydrochloride, aids in treating this condition. Levitra was first authorized for market use on August 19, 2003.

When will Levitra generic be available?

Levitra has a total of 2 drug patents. The generic version of Levitra might become available after July 23, 2027. This release date is anticipated because the last of Levitra's patents (US8273876) expires on that date.

Levitra uses

Levitra, containing vardenafil hydrochloride, is used for the treatment of erectile dysfunction. It comes in the form of a film-coated tablet to be administered orally.

Levitra patent expiration

Levitra holds two patents, out of which one has already expired. The last patent, US8273876, titled 'Medicaments containing vardenafil hydrochloride trihydrate,' is set to expire on July 23, 2027. Levitra generic will potentially be available after this date. Below are the details of the patent:

EPO Oppostions filed on Levitra

Levitra dosage

Want to ask something?